1Ances BM, Vitaliani R, Taylor RA, et al. Treatment-re- sponsive limbic encephalitis identified by neuropil antibodies: MR1 and PET correlates E. Brain, 2005, 128: 1764-1777.
3Iizuka T,Sakai F.Anti-NMDA receptor encephalitis in Japan:long-term outcome without tumor removal[J].Neurology,2008,70(7):504-511.
4Iizuka T,Sakai F.Update on anti-NMDA receptor encephalitis[J].Brain Nerve,2010,62(4):331-338.
5Forrest D,Yuzaki M,Soares HD,et al.Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death[J].Neuron,1994,13:325-338.
6Dalmau J,Gleichman AJ.Anti-NMDA-receptor encephalitis:case series and analysis of the effects of antibodies[J].Lancet Neurol,2008,7(12):1091-1098.
7Ishiura H,Matsuda S.Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab[J].Neurology,2008,71(23):1921-1923.
8Whitley RJ.Herpes simp lex encephalitis:adolescents and adults[J].Antiviral Res,2006,71(2-3):141 -148.
9Chong JY,Rowland LP,Utiger RD.Hashimoto encephalo-pathy.Syndrome or myth?[J].Arch Neurol,2003,60:164-171.
10Seki M,Suzuki S,Iizuka T,et al.Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis[J].J Neurol Neurosurg Psychiatry,2008,79(3):324-326.